Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Morozova

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Leukemia|May 23, 2021
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMTNicolaus Kröger, Giulia Sbianchi, Tiarlan Sirait, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2026
Identification Of a Therapeutic Threshold For AAV-STXBP1 Gene Therapy in a Rodent Model of STXBP1 Developmental & Epileptic EncephalopathyNicholas B Gallo, John W Annand, Pete Clarner, et al.
Bone Marrow Transplantation|April 10, 2026
Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMTAlexandros Kanellopoulos, Linda Koster, Hugues de Lavallade, et al.
British Journal of Haematology|April 5, 2024
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMTFrancesco Onida, Luuk Gras, Junran Ge, et al.
Leukemia|March 29, 2024
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase RegistryAnnamaria Brioli, Elza Lomaia, Christian Fabisch, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Leukemia|May 23, 2021
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMTNicolaus Kröger, Giulia Sbianchi, Tiarlan Sirait, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2026
Identification Of a Therapeutic Threshold For AAV-STXBP1 Gene Therapy in a Rodent Model of STXBP1 Developmental & Epileptic EncephalopathyNicholas B Gallo, John W Annand, Pete Clarner, et al.
Bone Marrow Transplantation|April 10, 2026
Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMTAlexandros Kanellopoulos, Linda Koster, Hugues de Lavallade, et al.
British Journal of Haematology|April 5, 2024
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMTFrancesco Onida, Luuk Gras, Junran Ge, et al.
Leukemia|March 29, 2024
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase RegistryAnnamaria Brioli, Elza Lomaia, Christian Fabisch, et al.
Pageof 6